Related Experiment Video

Updated: Aug 25, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Novel therapies for patients with chronic myeloid leukemia

Francis J Giles1, Hagop Kantarjian, Jorge Cortes

  • 1Department of Leukemia, Box 428, University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA. frankgiles@aol.com

Expert Review of Anticancer Therapy
|April 2, 2004
PubMed

Insights

Optimizing imatinib mesylate (Gleevec) use and developing new therapies for chronic myeloid leukemia (CML) patients resistant to imatinib are crucial for long-term survival. Novel agents targeting Bcr-Abl pathways offer potential synergistic treatments and cures for CML.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Chronic myeloid leukemia (CML) survival hinges on optimal imatinib mesylate (Gleevec) use.
  • Resistance to imatinib and intolerance necessitate development of alternative therapies.
  • Investigating novel agents in imatinib-resistant CML patients presents challenges due to confounding factors.

Purpose of the Study:

  • To address critical issues impacting long-term survival in chronic myeloid leukemia (CML) patients.
  • To explore the role of imatinib mesylate (Gleevec) and alternative therapies.
  • To understand the therapeutic potential of novel agents in imatinib-resistant CML.

Main Methods:

  • Review of current therapeutic strategies for CML.
  • Analysis of novel agents targeting Bcr-Abl pathways.
  • Evaluation of synergistic relationships between imatinib and new agents.

Main Results:

  • Optimal imatinib mesylate (Gleevec) use is key for CML patient survival.
  • Novel agents are being developed for imatinib-resistant or intolerant CML patients.
  • Diverse mechanisms of action for new agents suggest potential synergistic effects with imatinib.

Conclusions:

  • Complete blockade of Bcr-Abl pathways is essential for CML treatment.
  • Reversing apoptotic and angiogenic abnormalities may lead to CML cures.
  • Targeted therapies offer hope for improved long-term outcomes in chronic myeloid leukemia.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...